SB 6116 Washington Senate · 2025-2026 Regular Session

Restoring funding for cancer research and public health services.

The bill title claims to address cancer research funding, but the provided text actually amends tobacco product tax definitions (RCW 82.26.010), not funding for public health services. The text defines terms like "tobacco products," "retailer," "taxable sales price," and "distributor" for tax purposes. It contains no provisions about restoring funding for cancer research, public health services, or any policy changes related to health funding. The bill appears to be a procedural tax code amendment, not the health funding measure described in its title. The context provided does not support the title's claim.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 14, 2026 Last action Jan 22, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
1
Committee
1
Jan 22, 2026
Upper · Passed
Public hearing in the Senate Committee on Ways & Means at 4:00 PM.
upper
1 primary · 6 co-sponsors

Sponsors